Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genta deal

The San Diego company expanded its Genta Jago drug delivery joint venture with Jagotec AG by adding worldwide rights to develop and commercialize oral controlled-release formulations of 35

Read the full 288 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE